Anti-photoaging effect and mechanism of flexible liposomes co-loaded with apigenin and doxycycline

Biomed Pharmacother. 2023 Aug:164:114998. doi: 10.1016/j.biopha.2023.114998. Epub 2023 Jun 8.

Abstract

Prolonged exposure to UV light can lead to photo-ageing of the skin. Therefore, the development and application of anti-photoaging drugs is urgent. In this study, we co-loaded apigenin (Apn) and doxycycline (Doc), a broad-spectrum inhibitor of matrix metalloproteinases (MMPs), into flexible liposomes to exert anti-photoaging effects by combating oxidative stress, anti-inflammation, reducing the activation of MMPs and preventing collagen loss. The results showed that we prepared a flexible liposome (A/D-FLip) containing Apn and Doc. Its appearance, particle size and Zeta potential were normal and it had good encapsulation efficiency, drug loading, in vitro release and transdermal efficiency. In cellular experiments, A/D-FLip could inhibit oxidative stress damage, reduce inflammatory factors and decrease the activation of MMPs in Human immortalized keratinocytes (HaCaT) cells; in animal experiments, A/D-FLip could inhibit skin damage and reduce skin collagen loss by decreasing the activation of MMPs, thus inhibiting skin photoaging in mice. In conclusion, A/D-FLip has good anti-photoaging effects and it has the potential to become an effective skin care product or drug against UV damage and skin photoaging in the future.

Keywords: Apigenin; Doxycycline; Flexible liposomes; Matrix metalloproteinases; Photoaging.

MeSH terms

  • Animals
  • Apigenin / pharmacology
  • Collagen / pharmacology
  • Doxycycline / pharmacology
  • Humans
  • Liposomes* / pharmacology
  • Matrix Metalloproteinases
  • Mice
  • Skin
  • Skin Aging*
  • Ultraviolet Rays / adverse effects

Substances

  • Liposomes
  • Apigenin
  • Doxycycline
  • Collagen
  • Matrix Metalloproteinases